Weekly plain-language updates on clinical trial activity, written for patients and caregivers. TrialsAlert publishes research updates every Friday covering the most notable trials across all monitored conditions.
Clinical trial research updates are weekly summaries of new and updated clinical trials published on ClinicalTrials.gov, the world's largest registry of clinical studies. Each update covers a specific medical specialty or condition, highlighting the most significant trials from the past week. Our AI scores each trial across six dimensions — phase importance, breakthrough potential, patient accessibility, condition prevalence, sponsor credibility, and relevance — then classifies them as breakthrough, notable, or routine. The resulting briefings explain what changed, who is sponsoring the research, what phase it is in, and why it matters for patients, all in plain English without medical jargon. These updates serve patients, caregivers, and support communities who want to stay informed about clinical research without spending hours searching databases themselves.
June 19, 2026 — 5 trials covered | Immunology
Evaluation of ALLERgen Specific Vaccination of DOG Allergic Patients in Swedish Practice This Phase 4 trial is testing a new allergy vaccine for adults with moderate to severe dog allergy and asthma. ...
June 19, 2026 — 5 trials covered | Urology
Assessing Suzetrigine for Pain Reduction Following Ureteroscopic Surgery This Phase 3 study is exploring suzetrigine, a new non-opioid medication, to help manage pain after ureteroscopic surgery, whic...
June 19, 2026 — 5 trials covered | Rare Diseases
Pediatric Patients Aged 1 to 6 Years With APDS This Phase 3 trial is testing leniolisib, an oral medication, in young children with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS), a rare im...
June 19, 2026 — 5 trials covered | Autoimmune & Rheumatology
Trial of Belimumab in Early Lupus This Phase 4 trial is studying belimumab, a treatment designed to modify the immune system, in people with early-stage lupus. The goal is to see if starting belimumab...
June 19, 2026 — 5 trials covered | Kidney Disease & Nephrology
Pivotal Study of the Velocity™ pAVF System This study is testing a new, less invasive way to create access for dialysis in adults with kidney failure. The Velocity pAVF System may reduce the need for ...
June 19, 2026 — 5 trials covered | Skin Conditions & Dermatology
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight This Phase 3 trial from Eli Lilly and Company explored the combinati...
June 19, 2026 — 5 trials covered | Eye Disease & Ophthalmology
Evaluation of the Impact of Oral Ivermectin on Musca Sorbens Flies, Putative Vector of Trachoma This Phase 4 trial is exploring whether oral ivermectin can reduce the population of Musca sorbens flies...
June 19, 2026 — 5 trials covered | Women's Health & Gynecology
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study This study is exploring a new non-invasive blood test for pregnant individuals to assess fetal genetic condi...
June 19, 2026 — 5 trials covered | Pediatrics & Child Health
GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward This Phase 4 trial is studying the medication semaglutide combined with lifestyle changes to help adolescents with obesity. If the stud...
June 19, 2026 — 5 trials covered | Lung & Respiratory Disease
Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma This Phase 3 trial studied tezepelumab, a new biologic medicine for adults with ...
June 19, 2026 — 5 trials covered | Diabetes & Endocrinology
A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before This Phase 3 study looked a...
June 19, 2026 — 5 trials covered | Digestive Health & Gastroenterology
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis This Phase 3 trial is exploring the use of filgotinib, an oral medication, for children and teenagers age...
June 19, 2026 — 5 trials covered | Infectious Disease
SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years This Phase 3 trial is exploring a new varicella vaccine regimen for children aged 12 months to 12 yea...
June 19, 2026 — 5 trials covered | Blood Disorders & Hematology
Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level This Phase 3 trial from the University of Leeds is exploring personalized immuno...
June 19, 2026 — 5 trials covered | Orthopedics & Musculoskeletal
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Fracture Surgery This study is exploring a new nerve block technique that uses liposomal bupivacaine to provide longer-lasting p...
June 19, 2026 — 5 trials covered | Mental Health & Psychiatry
EEG Biomarkers for ADHD Stimulant Treatment This Phase 4 trial led by Boston Children’s Hospital is exploring whether brain activity patterns measured by EEG can help predict which stimulant medicatio...
June 19, 2026 — 5 trials covered | Heart Disease & Cardiology
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI This Phase 4 trial is exploring a new combination of blood-thinning medications, dabi...
June 19, 2026 — 5 trials covered | Neurology & Brain Disorders
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6) This Phase 3 trial explores new dosing schedules of donanemab, a treatment desig...
June 19, 2026 — 5 trials covered | Cancer & Oncology
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial This phase III trial is testing whether adding tucat...
June 12, 2026 — 5 trials covered | Immunology
Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases This Phase 3 trial is testi...
June 12, 2026 — 5 trials covered | Rare Diseases
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE) ...
June 12, 2026 — 5 trials covered | Autoimmune & Rheumatology
Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica This Phase 3 trial is exploring baricitinib, a pill taken by mouth, as a treatme...
June 12, 2026 — 5 trials covered | Urology
Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma This Phase 2 trial from Yale University is exploring whether adding surgery or other local treatments after initial systemic ...
June 12, 2026 — 5 trials covered | Eye Disease & Ophthalmology
To Evaluate the Efficacy and Safety of N-acetyl Cysteine Administration in Patients With Diabetic Retinopathy This Phase 4 trial led by Ain Shams University is studying whether N-acetyl cysteine, an o...
June 12, 2026 — 5 trials covered | Kidney Disease & Nephrology
Mechanism of SGLT2 Inhibition in the Kidney This Phase 4 trial from the University of Michigan is exploring how SGLT2 inhibitors, such as Canagliflozin, affect kidney function in adults with type 2 di...
June 12, 2026 — 5 trials covered | Skin Conditions & Dermatology
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis This Phase 3 trial is testing deucravacitin...
June 12, 2026 — 5 trials covered | Pediatrics & Child Health
Morphine or Ketamine for Analgesia This Phase 3 trial led by Columbia University is comparing intravenous ketamine to morphine for treating acute pain in children with conditions like abdominal pain a...
June 12, 2026 — 5 trials covered | Women's Health & Gynecology
Xylitol and the Prevention of Periodontal Disease and Preterm Birth Trial This study is exploring whether chewing gum containing xylitol can help reduce the chances of preterm birth and low birthweigh...
June 12, 2026 — 5 trials covered | Lung & Respiratory Disease
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and Older This Phase 3 study evaluates a triple combination drug treatment for cystic fibros...
June 12, 2026 — 5 trials covered | Digestive Health & Gastroenterology
Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) This Phase 2 study is exploring a new RNA-based treatment called ALN-CIDEB for adults with f...
Subscribe to get weekly briefings for your specific condition.